Showing results (621-630 of 1,351) with videos related to

Sort By:
Pageof 136
Clinical Pharmacology in Drug Development|June 28, 2023
Safety, Pharmacokinetics, and Antifibrotic Activity of CC-90001 (BMS-986360), a c-Jun N-Terminal Kinase Inhibitor, in Pulmonary FibrosisGerald Horan, Ying Ye, Mary Adams, et al.
Clinical Pharmacology in Drug Development|June 10, 2023
Bioequivalence Study of Miglitol Orally Disintegrating Tablets in Healthy Chinese Volunteers Under Fasting Condition Based on Pharmacodynamic and Pharmacokinetic ParametersMing-Xuan Zhao, Jin-Lian Wu, Li-Chun Dong, et al.
Clinical Pharmacology in Drug Development|September 20, 2023
Bioequivalence of Reference and Biosimilar Preparations of Premixed Biphasic Insulin Aspart: A Comparative Clamp StudyArtem Dorotenko, Igor Makarenko, Tatiana Karonova, et al.
Clinical Pharmacology in Drug Development|September 8, 2023
A Randomized Control Study in Healthy Adult Smokers to Assess Reduced Exposure to Selected Cigarette Smoke Constituents in Switching to the Novel Heated Tobacco Product DT3.0aDaisuke Nishihara, Dai Yuki, Takuya Suzuki, et al.
Clinical Pharmacology in Drug Development|September 14, 2023
Pharmacokinetics of Alglucosidase Alfa Manufactured at the 4000-L Scale in Participants with Pompe Disease: A Phase 3/4 Open-Label StudyXavier Nicolas, Fabrice Hurbin, Magali Periquet, et al.
Clinical Pharmacology in Drug Development|June 14, 2023
Pharmacokinetics and Bioequivalence of Mirogabalin Orally Disintegrating Tablets and Conventional Tablets in Healthy Japanese ParticipantsKaoru Toyama, Takashi Eto, Kanae Suzuki, et al.
Clinical Pharmacology in Drug Development|May 27, 2023
Pharmacokinetics of Nifedipine-Sustained Release Tablets in Healthy Subjects After a Single Oral Administration: Bioequivalence Analysis and Food EffectsYou-Xuan Wu, Xue-Feng Zhong, Xiao-Min Li, et al.
Clinical Pharmacology in Drug Development|March 5, 2026
Absolute Bioavailability and Absorption, Distribution, Metabolism, and Excretion of [14C]Xevinapant, a Potent, Oral, Small-Molecule IAP InhibitorAnnick Menetrey, Valérie Nicolas-Metral, Marie-Claude Roubaudi-Fraschini, et al.
Clinical Pharmacology in Drug Development|March 9, 2026
Results of a Phase 1 Study Assessing the Effect of CIN-102, a Novel Formulation of the Dopamine Receptor Antagonist Domperidone Designed to Treat Gastroparesis, on Cardiac Repolarization in Healthy VolunteersMary Bond, Brian Murphy, Brendan Doran, et al.
Clinical Pharmacology in Drug Development|February 24, 2026
Pharmacokinetics and Safety of VV116 in Subjects With Mild or Moderate Hepatic Impairment Compared With Healthy Controls: A Phase I, Open-Label StudyXi Tan, Tong Lu, Shijuan Kuang, et al.
Pageof 136